PET Radioligands for Rheumatoid Arthritis

"As of now, clinicaltrials.gov suggests that this medical study is still seeking participants since its inception in June 14th 2019 and last update on October 14th 2022."

"This clinical trial seeks 96 participants with myositis, aged between 18 and 99. The essential prerequisites are as follows: 1) Healthy subjects must be of or above the age of consent, willing to comply with all study protocols, medically sound, enrolled in either protocol #01M0254 "The Evaluation of Participants with Mood and Anxiety Disorders and Healthy Volunteers" or # 17-M-0181 "Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies", age-, sex-, genotype-matched candidates if applicable (Phase 2), females who have no plans to become pregnant within 3"

"There is limited data on safety and efficacy, so this intervention was estimated to have a score of 1."

"Affirmative. The clinicaltrials.gov website indicates that this investigation is actively recruiting participants, with the first post dating back to June 14th 2019 and a recent edit on October 14th 2022. 96 individuals are sought after at 1 centre of research."

"This medication has typically been employed to reduce pain, but it is also helpful for managing other maladies such as primary dysmenorrhoea, rheumatoid arthritis, and ankylosing spondylitis."

"This trial is looking for patients that are between 18 and 99 years of age. For minors, there are 111 clinical trials available, whereas those over 65 have access to 748 different studies."